Galecto Daily News Today

Galecto, Inc. (NASDAQ:GLTO – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 9,300 shares, a drop of 80.4% from the May 15th total of 47,400 shares. Approximately 0.1% of the company’s stock are short sold. Based […]

Galecto (NASDAQ:GLTO – Get Free Report) and Achaogen (OTCMKTS:AKAOQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Volatility and Risk Galecto has a beta of 1.26, […]

Galecto, Inc. (NASDAQ:GLTO – Get Free Report)’s stock price was up 1.8% during mid-day trading on Monday . The stock traded as high as $0.73 and last traded at $0.72. Approximately 579,002 shares traded hands during mid-day trading, an increase of 89% from the average daily volume of 307,100 shares. The stock had previously closed […]

Shares of Galecto, Inc. (NASDAQ:GLTO – Get Free Report) have received a consensus rating of “Hold” from the seven research firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […]

Galecto, Inc. (NASDAQ:GLTO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among brokers […]

Galecto, Inc. (NASDAQ:GLTO – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective […]

Galecto (NASDAQ:GLTO – Free Report) had its target price lowered by HC Wainwright from $12.00 to $2.00 in a research note issued to investors on Monday morning, MarketBeat reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Galecto’s Q3 2023 earnings at ($0.38) EPS, Q4 2023 earnings […]

Galecto, Inc. (NASDAQ:GLTO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price target […]

Galecto, Inc. (NASDAQ:GLTO – Get Free Report) has been given a consensus recommendation of “Buy” by the four analysts that are presently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have covered the stock in the last year is $11.50. […]

Galecto, Inc. (NASDAQ:GLTO – Get Free Report) major shareholder Orbimed Advisors Llc sold 209,400 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $3.00, for a total value of $628,200.00. Following the sale, the insider now owns 135,531 shares in the […]